Target intelligence / Profile preview

X-C motif chemokine receptor 1 (XCR1)

Target
XCR1
Molecular classification
G protein-coupled receptor, Chemokine receptor, Receptor
01

Overview

X-C motif chemokine receptor 1 (XCR1) is the sole member of the "C" sub-family of chemokine receptors, functioning as a G protein-coupled receptor that binds the chemokines XCL1 and XCL2 (lymphotactin-1 and -2). It is expressed primarily on a specialized subset of dendritic cells (DCs), specifically CD8α+ in mice, BDCA3+ in humans, and CD26+ in sheep, and is highly conserved among vertebrates. XCR1 mediates chemotaxis, increases intracellular calcium, and is crucial for efficient antigen cross-presentation and induction of cytotoxic CD8+ T cell responses, thus supporting both the innate and adaptive immune systems. It has restricted tissue distribution and plays key roles in immune surveillance, controlling infection, and potentially in cancer immunotherapy. MIP-II is a known antagonist, and functional interaction sites between its ligand, XCL1, and XCR1 have been characterized structurally. No direct clinical drugs are approved that target XCR1, but the axis is being investigated as a potential immunotherapeutic and vaccine target, especially due to its role in selectively guiding DCs and T cell interactions.

Other names
CCXCR1XC chemokine receptor 1Chemokine (C motif) receptor 1Chemokine XC receptor 1G protein-coupled receptor 5 (GPR5)
02

Mechanism of action

Drugs or molecules that act on XCR1 typically modulate immune cell migration and activation by antagonizing or agonizing its interaction with its chemokine ligand XCL1, thereby modulating the immune response. Antagonists such as MIP-II can block receptor signaling.

03

Biological functions

Signal transductionImmune responseCell migration (chemotaxis)Antigen cross-presentation
04

Disease associations

InfectionCancerInflammation
05

Safety considerations

Manipulating this chemokine axis could potentially impact normal immune cell function and surveillance.Therapeutic targeting may affect antigen presentation and immune activation, posing risks of immunosuppression or autoimmunity.
06

Interacting drugs

No FDA-approved drugs are currently listed as directly targeting XCR1.

1 more in the full profile.

07

Biomarkers

XCR1 expression marks specialized dendritic cell subsets; its status is used to identify these populations for immune surveillance and research

Beyond the preview

Go deeper on X-C motif chemokine receptor 1 (XCR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on X-C motif chemokine receptor 1 (XCR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call